Margaret O'Connor, MD, PhD

General Surgery Resident
Duke University
Durham, North Carolina, United States

Presentation(s):

• P40. Receipt of adjuvant checkpoint inhibitor therapy for melanoma and risk of subsequent skin cancer

  Thursday, March 5, 2026
  2:18 PM - 2:25 PM MST

• P48. Duration of adjuvant immunotherapy in sentinel node positive melanoma: How important is completing a full year?

  Thursday, March 5, 2026
  3:14 PM - 3:21 PM MST

• QS20. The melanocytic transcriptomic state is independently associated with poor overall survival in long term follow up of patients with metastatic melanoma

  Thursday, March 5, 2026
  3:37 PM - 3:41 PM MST